|
TRIP13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87659998651668E-09 |
| Normal-vs-Stage2 |
2.059000E-03 |
| Normal-vs-Stage3 |
3.96730000000733E-05 |
| Normal-vs-Stage4 |
3.457300E-03 |
| Stage1-vs-Stage2 |
9.722200E-01 |
| Stage1-vs-Stage3 |
2.024200E-02 |
| Stage1-vs-Stage4 |
5.527900E-02 |
| Stage2-vs-Stage3 |
6.021500E-02 |
| Stage2-vs-Stage4 |
4.891600E-02 |
| Stage3-vs-Stage4 |
7.691200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.35860000027854E-07 |
| Normal-vs-Asian |
4.775600E-02 |
| Caucasian-vs-AfricanAmerican |
6.636100E-02 |
| Caucasian-vs-Asian |
6.767800E-01 |
| AfricanAmerican-vs-Asian |
9.331600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.75609999986115E-07 |
| Male-vs-Female |
9.107900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.65010000002997E-07 |
| Normal-vs-Extreme_Weight |
7.97839572186376E-11 |
| Normal-vs-Obese |
1.53496999999447E-05 |
| Normal-vs-Extreme_Obese |
3.621900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.740830E-01 |
| Normal_Weight-vs-Obese |
5.547400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.192000E-01 |
| Extreme_Weight-vs-Obese |
1.064850E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.840000E-01 |
| Obese-vs-Extreme_Obese |
6.069800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.398490E-03 |
| Normal-vs-Age(41-60Yrs) |
1.64424029946986E-12 |
| Normal-vs-Age(61-80Yrs) |
4.60740001706483E-10 |
| Normal-vs-Age(81-100Yrs) |
3.775400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.646000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.949900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.698100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.689600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.718800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.472200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
1.2682999983582E-08 |
| Normal-VS-KIRP CIMP |
2.701800E-03 |
| Normal-VS-Unclassified PRCC |
1.998460E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.085590E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.496320E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.306840E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.972400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.133800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.027020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.81109999617146E-08 |
| Normal-vs-N1 |
4.21230000000605E-05 |
| Normal-vs-N2 |
1.808190E-01 |
| N0-vs-N1 |
5.842200E-03 |
| N0-vs-N2 |
3.770600E-01 |
| N1-vs-N2 |
9.161800E-01 |
|
|
